BlueWillow Biologics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults (NCT05397119) | BlueWillow Biologics | 2022-07-07 |
| A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults (NCT04148118) | BlueWillow Biologics | 2020-01-08 |
Track BlueWillow Biologics automatically
Every clearance here is in the API, with alerts when new ones post.